Skip To Main Content
Shuying Yang on Muck Rack

Shuying Yang

As seen in: Nature, Wiley Online Library, Frontiers, MDPI, Science Magazine, Royal Society of Chemistry, Canadian Journal of Infectious Diseases & Medical Microbiology, European Respiratory Journal, The Journal of Biological Chemistry, Pakistan Journal of Medical Sciences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Shuying

Contact Shuying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Delamination Prediction and Multi‐Objective Optimization in Ultrasonic Vibration‐Assisted Helical Milling (UVHM) of UHMWPE Composites

|
By Yaoting Wang, Lei Zheng, Zhiming Jiang, Haoxiang Wang, Shuying Yang, Yong feng, Jinqi Zai
| Wiley Online Library Verified
Delamination Prediction and Multi‐Objective Optimization in Ultrasonic Vibration‐Assisted Helical Milling (UVHM) of UHMWPE Composites - Wang - Polymer Composites - Wiley Online Library
Open in Who Shared Issue with article?

An asymptomatic WASF1 truncation reveals pathogenic mechanism and therapeutic strategy for neurodevelopmental disorders

|
By Shaojuan Song, Zongli Yang, Xiang Wang, Yajing zhang, Jiaxuan Wang, Shuying Yang, Jiayu Chen, Pu Wang, Juanchun Gao
| Frontiers
Abstract Introduction: Wiskott–Aldrich syndrome protein family member 1 (WASF1) truncating variants, such as c.1516C>T (p.Arg506Ter), are established causes of neurodevelopmental disorders (NDDs), but their underlying pathogenic mechanism remains debated. This study aimed to clarify the disease mechanism and identify potential therapeutic leads.
Open in Who Shared Issue with article?

Model‐Informed Drug Development for Daprodustat Supports the Design of Individualized Dosing Regimens in Chronic Kidney Disease Patients With Anemia

|
By Kelly M. Mahar, Shuying Yang, Brendan Johnson Verified, Sandra Visser
| Wiley Online Library Verified
GETTING THE DOSE RIGHT: A MODEL-INFORMED APPROACH TO INDIVIDUALIZED THERAPY Selecting the right dose is one of the most critical—and often most challenging—decisions in clinical drug development.
Open in Who Shared Issue with article?
See all 15 licensed articles (17 Total)